| Q57459857 | A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancer |
| Q36647747 | A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo |
| Q37177892 | Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts. |
| Q28564696 | An essential role for the integrin-linked kinase-glycogen synthase kinase-3 beta pathway during dendrite initiation and growth |
| Q33709656 | Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts |
| Q38340042 | CABYR RNAi plasmid construction and NF-κB signal transduction pathway |
| Q37118092 | Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis. |
| Q35571884 | Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma. |
| Q37129806 | Foxo in the immune system |
| Q36352100 | From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy |
| Q48428544 | Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway |
| Q36922997 | Immune regulation by Foxo transcription factors |
| Q40224632 | Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines |
| Q36625236 | Inhibitors of signal transduction protein kinases as targets for cancer therapy |
| Q33644080 | Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target |
| Q28299126 | Integrin signalling adaptors: not only figurants in the cancer story |
| Q36930821 | Integrin-Linked Kinase in Muscle Is Necessary for the Development of Insulin Resistance in Diet-Induced Obese Mice |
| Q28749480 | Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylation |
| Q35180008 | Integrin-linked kinase regulates the rate of platelet activation and is essential for the formation of stable thrombi |
| Q43119912 | Integrin-linked kinase: both Jekyll and Hyde in rhabdomyosarcoma |
| Q37878251 | Integrin-linked kinase: not so 'pseudo' after all. |
| Q37209242 | JNK1 determines the oncogenic or tumor-suppressive activity of the integrin-linked kinase in human rhabdomyosarcoma |
| Q42275835 | LY294002 enhances inhibitory effect of gemcitabine on proliferation of human pancreatic carcinoma PANC-1 cells |
| Q46548978 | Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. |
| Q35157985 | Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders |
| Q84717295 | Mechanotransduction activates α₅β₁ integrin and PI3K/Akt signaling pathways in mandibular osteoblasts |
| Q34210068 | MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression |
| Q36512542 | Modulation of response to tumor therapies by the extracellular matrix |
| Q39250668 | Molecular predictors of gemcitabine response in pancreatic cancer |
| Q36519041 | New therapies for hepatocellular carcinoma. |
| Q57112652 | OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics |
| Q33241062 | On systems and control approaches to therapeutic gain |
| Q38974336 | Opportunities to Target Specific Contractile Abnormalities with Smooth Muscle Protein Kinase Inhibitors |
| Q24670990 | Pancreatic cancer: pathogenesis, prevention and treatment |
| Q37012318 | Particularly interesting cysteine- and histidine-rich protein in cardiac development and remodeling |
| Q39539512 | Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells |
| Q39601528 | Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells |
| Q36537788 | Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics |
| Q37277114 | QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatmen |
| Q36836615 | RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research |
| Q54203070 | Regulation of interferon signaling and HCV‑RNA replication by extracellular matrix |
| Q38815948 | Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells. |
| Q38686618 | Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells |
| Q37029162 | STAT3 as a target for inducing apoptosis in solid and hematological tumors |
| Q61808060 | Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer |
| Q39298534 | Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1) |
| Q34430583 | Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1 |
| Q48907560 | Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer. |
| Q30374421 | The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation |
| Q24675696 | The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes |
| Q36219713 | The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. |
| Q104111657 | The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy |
| Q38096803 | The rationale of targeting mammalian target of rapamycin for ischemic stroke |
| Q33489630 | The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck |
| Q37628723 | There's something about ILK. |
| Q54573803 | Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. |
| Q42698235 | Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype? |
| Q39217952 | Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition |
| Q40115872 | Ultrasound induces hypoxia-inducible factor-1 activation and inducible nitric-oxide synthase expression through the integrin/integrin-linked kinase/Akt/mammalian target of rapamycin pathway in osteoblasts. |
| Q36720975 | Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model |
| Q39608009 | c-Jun N-terminal kinase is involved in the regulation of proliferation and apoptosis by integrin-linked kinase in human retinoblastoma cells |
| Q41122817 | β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy |